Delayed recovery from rocuronium block in an infant

Inci Kara1, Ipek Duman, Ates Duman

  • 1Selcuk University, Selcuklu Medical Faculty, Department of Anesthesiology and Intensive Care, Konya, Turkey. drincikara@yahoo.com

Insights

Prolonged neuromuscular blockade from rocuronium is rare in infants. This case report details a unique instance of extended rocuronium effects during sevoflurane anesthesia for cleft lip repair in an infant.

Area of Science:

  • Anesthesiology
  • Pediatric Surgery
  • Pharmacology

Background:

  • Rocuronium is a common neuromuscular blocking agent used in pediatric anesthesia.
  • Maintaining adequate neuromuscular blockade and ensuring timely recovery are critical for patient safety.
  • Infants may exhibit different responses to anesthetic agents compared to older children and adults.

Observation:

  • An infant undergoing cleft lip repair experienced an unusually prolonged duration of neuromuscular blockade after rocuronium administration.
  • The patient was anesthetized using sevoflurane, a volatile anesthetic agent.
  • Standard monitoring indicated persistent neuromuscular blockade beyond the expected recovery time.

Findings:

  • The prolonged effect of rocuronium suggests potential pharmacokinetic or pharmacodynamic variations in this infant.
  • Possible contributing factors include immature metabolic pathways or altered receptor sensitivity in infants.
  • Sevoflurane anesthesia may have influenced the duration of action of rocuronium.

Implications:

  • This case highlights the importance of vigilant neuromuscular monitoring in infants receiving rocuronium.
  • Anesthesiologists should be prepared for prolonged neuromuscular blockade and have strategies for management.
  • Further research into the factors influencing rocuronium duration in neonates and infants is warranted.

Related Concept Videos

Depolarizing Blockers: Pharmocokinetics01:19

Depolarizing Blockers: Pharmocokinetics

Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacokinetics01:11

Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacokinetics

All neuromuscular blocking agents are injected intravenously because they are poorly absorbed from the GI tract. Rapid onset is achieved with intravenous administration, although absorption is also adequate from an intramuscular injection. Since these agents are highly ionized, they do not readily penetrate cell membranes or cross the blood-brain barrier.
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
Depolarizing Blockers: Mechanism of Action01:28

Depolarizing Blockers: Mechanism of Action

Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...
Skeletal Muscle Relaxants: Adverse Effects01:21

Skeletal Muscle Relaxants: Adverse Effects

Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions01:27

Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions

Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...